[1]Wang Z, Zhang J, Liu Y, et al. An integrated autophagy-related long noncoding rna signature as a prognostic biomarker for human endometrial cancer: a bioinformatics-based approach [J]. Biomed Res Int, 2020, 2020(12): 5717498.
[2]Liu H, Wan J, Feng Q, et al. Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway [J]. J Cell Commun Signal, 2022, 16(2): 253-270.
[3]Roh JW, Choi JE, Han HD, et al. Clinical and biological significance of EZH2 expression in endometrial cancer [J]. Cancer Biol Ther, 2020, 21(2): 147-156.
[4]Fang X, Ni N, Wang X, et al. EZH2 and endometrial cancer development: insights from a mouse model [J]. Cells, 2022, 11(5): 909.
[5]Audia JE, Campbell RM. Histone modifications and cancer[J]. Cold Spring Harb Perspect Biol, 2016, 8(4): a019521.
[6]Chen Q, Yang B, Liu X, et al. Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents [J]. Theranostics, 2022, 12(11): 4935-4948.
[7]McDonald M, Bender D. Endometrial cancer: obesity, genetics, and targeted agents [J]. Obstet Gynecol Clin North Am, 2019, 46(1): 89-105.
[8]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30.
[9]Mitric C, Bernardini MQ. Endometrial cancer: transitioning from histology to genomics[J]. Curr Oncol, 2022, 29(2): 741-757.
[10]Karpel HC, Slomovitz B, Coleman RL, et al. Treatment options for molecular subtypes of endometrial cancer in 2023 [J]. Curr Oncol, 2023, 35(3): 270-278.
[11]Fan J, Wu D, Guo Y, et al. SOS1-IT1 silencing alleviates MPP(+)-induced neuronal cell injury through regulating the miR-124-3p/PTEN/AKT/mTOR pathway [J]. J Clin Neurosci, 2022, 99(5): 137-146.
[12]Fu NN, Liu X, Liu T. Regulation of hepatocellular carcinoma cells by intronic long non coding RNA SOS1-IT1 [J]. Journal of Practical Medicine, 2021, 37(19): 2447-2452,2457. (in Chinese)
付楠楠, 刘蕊, 刘涛. 内含子源性长链非编码RNA SOS1?IT1对肝癌细胞的调控[J]. 实用医学杂志, 2021, 37(19): 2447-2452,2457.
[13]Lu HX, Wei DM, Feng ZhB. Expression and clinical significance of EZH2 in hepatocellular carcinoma[J]. Acta Anatomica Sinica, 2011, 42(1): 75-79. (in Chinese)
陆海霞,危丹明,冯震博. EZH2在肝细胞癌中的表达及临床意义[J],解剖学报, 2011, 42(1): 75-79.
[14]Chen L, Zheng X, Liu W, et al. Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer [J]. Cancer Lett, 2023, 578(12): 216445.